Purinergic signaling in nervous system health and disease: Focus on pannexin 1

Pharmacol Ther. 2021 Sep:225:107840. doi: 10.1016/j.pharmthera.2021.107840. Epub 2021 Mar 19.

Abstract

Purinergic signaling encompasses the cycle of adenosine 5' triphosphate (ATP) release and its metabolism into nucleotide and nucleoside derivatives, the direct release of nucleosides, and subsequent receptor-triggered downstream intracellular pathways. Since the discovery of nerve terminal and glial ATP release into the neuropil, purinergic signaling has been implicated in the modulation of nervous system development, function, and disease. In this review, we detail our current understanding of the roles of the pannexin 1 (PANX1) ATP-release channel in neuronal development and plasticity, glial signaling, and neuron-glial-immune interactions. We additionally provide an overview of PANX1 structure, activation, and permeability to orientate readers and highlight recent research developments. We identify areas of convergence between PANX1 and purinergic receptor actions. Additional highlights include data on PANX1's participation in the pathophysiology of nervous system developmental, degenerative, and inflammatory disorders. Our aim in combining this knowledge is to facilitate the movement of our current understanding of PANX1 in the context of other nervous system purinergic signaling mechanisms one step closer to clinical translation.

Keywords: Nervous system; Neurodevelopment; Neurological diseases; Nucleotides; Pannexin; Purinergic signaling.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adenosine Triphosphate* / metabolism
  • Connexins* / metabolism
  • Humans
  • Nerve Tissue Proteins* / metabolism
  • Nervous System Diseases
  • Neurons
  • Signal Transduction*

Substances

  • Connexins
  • Nerve Tissue Proteins
  • PANX1 protein, human
  • Adenosine Triphosphate

Grants and funding